| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Frazier Life Sciences Acquisition Corp. II Class A Ordinary Shares (FLSC) have been net buyers, picking up 300,000 shares worth roughly $3.0M on balance. In the past 30 days, 1 insider bought and 0 sold. The tilt toward buying has held up recently.
Cha Albert (Chief Executive Officer) stands out among recent buyers, now holding an estimated $3.0M in FLSC. Open-market purchases by a top executive tend to carry more weight than sales, which are often driven by diversification or scheduled 10b5-1 plans.
FLSC sits in the Shell Companies industry within the Financial Services sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 300.0K | $3.00M | +300.0K |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | Cha Albert | Chief Executive Officer | Buy | 300,000 | $10.00 | $3,000,000.00 | New |